申请人:Yumanity Therapeutics, Inc.
公开号:US20210139471A1
公开(公告)日:2021-05-13
The present invention features compounds useful in the treatment of neurological disorders and primary brain cancer. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders and primary brain cancer.